73 results
Page 3 of 4
6-K
EX-99.1
25qgy6cp8cdxtevu849
4 Jun 20
ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
6:11am
6-K
EX-99.2
kdtok 9o3n
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
wbbjg
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
1sz8qy8f6ygq7z7pj68v
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.3
38hzlbwwnf z1xesg
7 Nov 19
Current report (foreign)
9:11am
F-3
jjuh4sdch6biq6
7 Aug 19
Shelf registration (foreign)
8:24am
424B5
j4sk4q8y8s2 kx
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.1
tbvlm z6h47y
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.2
juvp8gl
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
42mnvo24q z5j3
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
EX-99.3
apv0r0v3 c5h7
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
EX-99.3
g7hkb 0rs
8 Aug 18
Index to Unaudited Consolidated Interim Financial Statements
7:00am
6-K
t99cx51obd51
25 Jul 18
Current report (foreign)
8:21am
6-K
EX-1.1
iidix
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
424B5
wq4g s37e
20 Jun 18
Prospectus supplement for primary offering
5:32pm
424B5
wpmm78 0knlz
18 Jun 18
Prospectus supplement for primary offering
9:15pm